• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care
Prostate Cancer : Episode 2

Episode 2 - Immunotherapy in CRPC

Video

During this segment, David Crawford, MD, discusses immunotherapy’s role in castration-resistant prostate cancer (CRPC), and explains how the US Food and Drug Administration’s approval of sipuleucel-T has led to a paradigm shift in the way that CRPC is treated.

Dr Crawford explains the unique capabilities of immunotherapy for advanced disease when compared to conventional treatment options such as cytotoxic chemotherapy.

Additionally, David Quinn, MD, discusses hormonal therapy agents, the key clinical trials that have tested these treatment options, and explains how the trials have demonstrated improved outcomes in CRPC.

Related Videos
Dr Sundar Jagannath
Screenshot of a webinar panel discussion with Viet Le, PA-C; Nathan Wong, PhD, MPH; Alison Bailey, MD; and Martha Gulati, MD, MS
Mehmet Oz, MD, MBA
Ayodeji Adegunsoye, MD, PhD, MSc
Marilyn Glassberg, MD
Dr Caroline Vovan
Interview with Miriam Freimer, MD, The Ohio State University Wexner Medical Center
Merrill H. Stewart, MD
Rachel Rohaidy, MD
Related Content
Elena Fenster | Background Image Credit: ipopba - stock.adobe.com

Contributor: Reframing Health Literacy—A Systemic Driver of Equity and Outcomes

July 29th 2025
Article

Improving health literacy is essential for promoting health equity, reducing preventable illness, and making health care more effective.

Read More

Managed Care Cast

Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD

July 15th 2025
Podcast

Sadie Dobrozsi, MD, of Evolent, discusses how predictive genomics is pushing cancer care into a new era of personalization

Listen

Long COVID graphic | Image Credit: Parradee - stock.adobe.com

Long COVID More Common Among Socially Vulnerable Individuals

July 28th 2025
Article

Social risk factors significantly increase the likelihood of developing long COVID, highlighting the urgent need for equitable health care and support systems.

Read More

Managed Care Cast

Why Collaborative Care Is the Path Forward for Mental Health Care: Anna Bobb, MPH

July 1st 2025
Podcast

Explore how the Collaborative Care Model enhances mental health access in this episode featuring Anna Bobb, MPH, executive director of the Path Forward coalition.

Listen

Doctor with patient | Image credit: Chinnapong - stock.adobe.com

5 Major Changes the Trump Administration Has Made in Health Care

July 25th 2025
Article

At the 6-month anniversary of the inauguration in January, The American Journal of Managed Care® looks back at the changes made by the Trump administration that could have lasting effects in health care.

Read More

The findings suggest that inhibition of midkine might be a meaningful tool to improve treatment outcomes in SCLC. | Image credit: Pixel-Shot - stock.adobe.com

Midkine May Play Key Role in SCLC

July 24th 2025
Article

New data show midkine expression is heightened in small cell lung cancer, suggesting the growth factor may be an important therapeutic target.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.